105 related articles for article (PubMed ID: 23139627)
1. Effect of triiodothyronine (T(3)) augmentation of acute milnacipran administration on monoamine levels: an in vivo microdialysis study in rats.
Kitaichi Y; Inoue T; Nakagawa S; Boku S; Kato A; Kusumi I; Koyama T
Neuropsychiatr Dis Treat; 2012; 8():501-7. PubMed ID: 23139627
[TBL] [Abstract][Full Text] [Related]
2. Subchronic milnacipran treatment increases basal extracellular noradrenaline concentrations in the medial prefrontal cortex of rats.
Kitaichi Y; Inoue T; Izumi T; Nakagawa S; Kato A; Koyama T
Eur J Pharmacol; 2005 Sep; 520(1-3):37-42. PubMed ID: 16153636
[TBL] [Abstract][Full Text] [Related]
3. Effect of milnacipran on extracellular monoamine concentrations in the medial prefrontal cortex of rats pre-treated with lithium.
Kitaichi Y; Inoue T; Nakagawa S; Izumi T; Koyama T
Eur J Pharmacol; 2005 Jun; 516(3):219-26. PubMed ID: 15963494
[TBL] [Abstract][Full Text] [Related]
4. A combination of mirtazapine and milnacipran augments the extracellular levels of monoamines in the rat brain.
Yamauchi M; Imanishi T; Koyama T
Neuropharmacology; 2012 Jun; 62(7):2278-87. PubMed ID: 22342987
[TBL] [Abstract][Full Text] [Related]
5. Effect of co-administration of a serotonin-noradrenaline reuptake inhibitor and a dopamine agonist on extracellular monoamine concentrations in rats.
Kitaichi Y; Inoue T; Izumi T; Nakagawa S; Tanaka T; Masui T; Koyama T
Eur J Pharmacol; 2008 Apr; 584(2-3):285-90. PubMed ID: 18336812
[TBL] [Abstract][Full Text] [Related]
6. Effects of serotonin-norepinephrine reuptake inhibitors on locomotion and prefrontal monoamine release in spontaneously hypertensive rats.
Umehara M; Ago Y; Fujita K; Hiramatsu N; Takuma K; Matsuda T
Eur J Pharmacol; 2013 Feb; 702(1-3):250-7. PubMed ID: 23376565
[TBL] [Abstract][Full Text] [Related]
7. Effects of acute and chronic reboxetine treatment on stress-induced monoamine efflux in the rat frontal cortex.
Page ME; Lucki I
Neuropsychopharmacology; 2002 Aug; 27(2):237-47. PubMed ID: 12093597
[TBL] [Abstract][Full Text] [Related]
8. Effect of co-administration of varenicline and antidepressants on extracellular monoamine concentrations in rat prefrontal cortex.
Rollema H; Wilson GG; Lee TC; Folgering JH; Flik G
Neurochem Int; 2011 Jan; 58(1):78-84. PubMed ID: 21056607
[TBL] [Abstract][Full Text] [Related]
9. Milnacipran enhances the control of impulsive action by activating D₁-like receptors in the infralimbic cortex.
Tsutsui-Kimura I; Ohmura Y; Izumi T; Kumamoto H; Yamaguchi T; Yoshida T; Yoshioka M
Psychopharmacology (Berl); 2013 Jan; 225(2):495-504. PubMed ID: 22892727
[TBL] [Abstract][Full Text] [Related]
10. Effect of co-administration of subchronic lithium pretreatment and acute MAO inhibitors on extracellular monoamine levels and the expression of contextual conditioned fear in rats.
Kitaichi Y; Inoue T; Nakagawa S; Izumi T; Koyama T
Eur J Pharmacol; 2006 Feb; 532(3):236-45. PubMed ID: 16487506
[TBL] [Abstract][Full Text] [Related]
11. Monoamine-dependent, opioid-independent antihypersensitivity effects of intrathecally administered milnacipran, a serotonin noradrenaline reuptake inhibitor, in a postoperative pain model in rats.
Obata H; Kimura M; Nakajima K; Tobe M; Nishikawa K; Saito S
J Pharmacol Exp Ther; 2010 Sep; 334(3):1059-65. PubMed ID: 20558774
[TBL] [Abstract][Full Text] [Related]
12. Mirtazapine-induced corelease of dopamine and noradrenaline from noradrenergic neurons in the medial prefrontal and occipital cortex.
Devoto P; Flore G; Pira L; Longu G; Gessa GL
Eur J Pharmacol; 2004 Mar; 487(1-3):105-11. PubMed ID: 15033381
[TBL] [Abstract][Full Text] [Related]
13. Chronopharmacological Analysis of Antidepressant Activity of a Dual-Action Serotonin Noradrenaline Reuptake Inhibitor (SNRI), Milnacipran, in Rats.
Kawai H; Machida M; Ishibashi T; Kudo N; Kawashima Y; Mitsumoto A
Biol Pharm Bull; 2018; 41(2):213-219. PubMed ID: 29386481
[TBL] [Abstract][Full Text] [Related]
14. Lipopolysaccharide increases degradation of central monoamines: an in vivo microdialysis study in the nucleus accumbens and medial prefrontal cortex of mice.
van Heesch F; Prins J; Konsman JP; Korte-Bouws GA; Westphal KG; Rybka J; Olivier B; Kraneveld AD; Korte SM
Eur J Pharmacol; 2014 Feb; 725():55-63. PubMed ID: 24444442
[TBL] [Abstract][Full Text] [Related]
15. Acute and repeated flibanserin administration in female rats modulates monoamines differentially across brain areas: a microdialysis study.
Allers KA; Dremencov E; Ceci A; Flik G; Ferger B; Cremers TI; Ittrich C; Sommer B
J Sex Med; 2010 May; 7(5):1757-67. PubMed ID: 20163532
[TBL] [Abstract][Full Text] [Related]
16. Differential effects of single and repeated ketamine administration on dopamine, serotonin and GABA transmission in rat medial prefrontal cortex.
Lindefors N; Barati S; O'Connor WT
Brain Res; 1997 Jun; 759(2):205-12. PubMed ID: 9221938
[TBL] [Abstract][Full Text] [Related]
17. Effects of cariprazine on extracellular levels of glutamate, GABA, dopamine, noradrenaline and serotonin in the medial prefrontal cortex in the rat phencyclidine model of schizophrenia studied by microdialysis and simultaneous recordings of locomotor activity.
Kehr J; Yoshitake T; Ichinose F; Yoshitake S; Kiss B; Gyertyán I; Adham N
Psychopharmacology (Berl); 2018 May; 235(5):1593-1607. PubMed ID: 29637288
[TBL] [Abstract][Full Text] [Related]
18. Effect of antidepressant drugs on monoamine synthesis in brain in vivo.
Moret C; Briley M
Neuropharmacology; 1992 Jul; 31(7):679-84. PubMed ID: 1357575
[TBL] [Abstract][Full Text] [Related]
19. (R)-Ketamine Induces a Greater Increase in Prefrontal 5-HT Release Than (S)-Ketamine and Ketamine Metabolites via an AMPA Receptor-Independent Mechanism.
Ago Y; Tanabe W; Higuchi M; Tsukada S; Tanaka T; Yamaguchi T; Igarashi H; Yokoyama R; Seiriki K; Kasai A; Nakazawa T; Nakagawa S; Hashimoto K; Hashimoto H
Int J Neuropsychopharmacol; 2019 Oct; 22(10):665-674. PubMed ID: 31325908
[TBL] [Abstract][Full Text] [Related]
20. The putative antidepressant DOV 216,303, a triple reuptake inhibitor, increases monoamine release in the prefrontal cortex of olfactory bulbectomized rats.
Prins J; Denys DA; Westphal KG; Korte-Bouws GA; Quinton MS; Schreiber R; Groenink L; Olivier B; Korte SM
Eur J Pharmacol; 2010 May; 633(1-3):55-61. PubMed ID: 20153745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
